Whittier Trust CO Of Nevada Inc Biomarin Pharmaceutical Inc Transaction History

Whittier Trust CO Of Nevada Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	BUY	$87.74 - $117.27 $2,544 - $3,400	29 New	29 $2,000
Q2 2022 Jul 28, 2022	SELL	$71.48 - $86.85 $4,074 - $4,950	-57 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$74.28 - $92.69 $7,502 - $9,361	-101 Reduced 63.92%	57 $4,000
Q4 2021 Jan 19, 2022	BUY	$71.72 - $91.47 $7,674 - $9,787	107 Added 209.8%	158 $14,000
Q3 2021 Nov 01, 2021	BUY	$74.77 - $85.47 $3,813 - $4,358	51 New	51 $4,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.